Literature DB >> 27169397

Metabolomic signatures in atherosclerotic disease: what is the potential use?

Peter M Nilsson1,2, Martin Magnusson2,3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27169397     DOI： 10.1038/hr.2016.44

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  12 in total

1.  Increased levels of small dense low-density lipoprotein cholesterol associated with hemorheological abnormalities in untreated, early-stage essential hypertensives.

Authors:  Masaki Takiwaki; Fumihiro Tomoda; Tsutomu Koike; Tomohiko Taki; Hiroshi Inoue; Mika Kigawa; Isaso Kitajima; Yoshinori Uji
Journal:  Hypertens Res       Date:  2014-07-03       Impact factor: 3.872

2.  Prognostic impact of arterial stiffness in patients with symptomatic peripheral arterial disease.

Authors:  J Kals; J Lieberg; P Kampus; M Zagura; J Eha; M Zilmer
Journal:  Eur J Vasc Endovasc Surg       Date:  2014-06-22       Impact factor: 7.069

3.  Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.

Authors:  Svati H Shah; Jie-Lena Sun; Robert D Stevens; James R Bain; Michael J Muehlbauer; Karen S Pieper; Carol Haynes; Elizabeth R Hauser; William E Kraus; Christopher B Granger; Christopher B Newgard; Robert M Califf; L Kristin Newby
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

Review 4.  Metabolomics in hypertension.

Authors:  Sonja B Nikolic; James E Sharman; Murray J Adams; Lindsay M Edwards
Journal:  J Hypertens       Date:  2014-06       Impact factor: 4.844

5.  Metabolite profiles and the risk of developing diabetes.

Authors:  Thomas J Wang; Martin G Larson; Ramachandran S Vasan; Susan Cheng; Eugene P Rhee; Elizabeth McCabe; Gregory D Lewis; Caroline S Fox; Paul F Jacques; Céline Fernandez; Christopher J O'Donnell; Stephen A Carr; Vamsi K Mootha; Jose C Florez; Amanda Souza; Olle Melander; Clary B Clish; Robert E Gerszten
Journal:  Nat Med       Date:  2011-03-20       Impact factor: 53.440

6.  A diabetes-predictive amino acid score and future cardiovascular disease.

Authors:  Martin Magnusson; Gregory D Lewis; Ulrika Ericson; Marju Orho-Melander; Bo Hedblad; Gunnar Engström; Gerd Ostling; Clary Clish; Thomas J Wang; Robert E Gerszten; Olle Melander
Journal:  Eur Heart J       Date:  2012-12-13       Impact factor: 29.983

7.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

8.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Journal:  J Am Coll Cardiol       Date:  2009-06-02       Impact factor: 24.094

9.  Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function.

Authors:  Toru Kato; Akira Umeda; Kazuya Miyagawa; Hiroshi Takeda; Taichi Adachi; Shigeru Toyoda; Isao Taguchi; Teruo Inoue; Koichi Node
Journal:  Hypertens Res       Date:  2014-03-20       Impact factor: 3.872

10.  Dimethylglycine Deficiency and the Development of Diabetes.

Authors:  Martin Magnusson; Thomas J Wang; Clary Clish; Gunnar Engström; Peter Nilsson; Robert E Gerszten; Olle Melander
Journal:  Diabetes       Date:  2015-03-20       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.